Opportunity
The accurate determination of cell cycle stage distribution is critical in biomedical research, particularly in drug development and cancer studies. Existing techniques, such as flow cytometry, western blotting, and time-lapse microscopy, are widely used but suffer from significant limitations. These methods often involve complex, multi-step procedures, including cell fixation, staining, and extensive sample preparation, which are time-consuming and incompatible with high-throughput screening. Flow cytometry, for instance, requires precise DNA staining and extensive washing steps, leading to potential variability and reduced reproducibility. Additionally, these techniques may not provide real-time or dynamic insights into cell cycle progression, limiting their utility in rapid drug efficacy assessments or large-scale studies. There is a pressing need for a simpler, faster, and more reproducible method to analyze cell cycle stages, especially for mammalian cells, to accelerate research in oncology, regenerative medicine, and toxicology.
Technology
The patent introduces an innovative method based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to determine cell cycle stage distribution. Instead of traditional proteomic profiling, this invention directly uses the mass spectrum generated from whole, unfixed cells to characterise cell cycle stages. The technology addresses existing limitations by streamlining sample preparation and analysis. Key steps include:
1. Cell Sample Preparation: Cells (intact or lysed) are pre-treated with a solvent (e.g., purified water or PBS) to remove interfering salts/buffers, enhancing signal clarity.
2. Matrix Mixing: The sample is mixed with a matrix solution (e.g., CHCA in acetonitrile/TFA) to facilitate ionization.
3. Mass Spectrometry: The mixture is deposited on a sample plate, and MALDI-TOF MS generates a mass spectrum.
4. Marker Peak Identification: At least two marker peaks (e.g., 8460 Da and 8574 Da for HeLa cells) are identified, with their ratio correlating to specific cell cycle stages (G1, S, G2/M).
The innovation lies in the use of MALDI-TOF MS for mammalian cell cycle analysis, a previously underexplored application. The method eliminates the need for DNA staining or fixation, reduces processing time, and improves reproducibility. Synchronization techniques (e.g., double thymidine block) further enhance accuracy by aligning cells to specific cycle stages.
Advantages
- High Throughput: Compatible with automated platforms for large-scale screening.
- Minimal Sample Preparation: No fixation or staining required, reducing artifacts.
- Reproducibility: Low coefficient of variation (<30%) in="" peak="" intensity="">
- Versatility: Applicable to intact cells or lysates, across mammalian and prokaryotic cells.
- Dynamic Monitoring: Tracks real-time changes in cell cycle progression.
Applications
- Cancer Research: Evaluating drug effects on tumor cell cycles.
- Drug Development: High-throughput screening of compounds targeting cell proliferation.
- Stem Cell Studies: Monitoring differentiation and proliferation dynamics.
- Toxicology: Assessing chemical impacts on cell cycle integrity.
- Diagnostics: Rapid profiling of aberrant cell cycles in clinical samples.
